Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,276,346
+$171,466 QoQ
Shares Held
16,838
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,727
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Cleef Asset Management,Inc holds $14,679,161 across 8 Drug Manufacturers - General names. JNJ ranks #1 (29.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
16,838 | $4,276,346 | |
| 2 | LLY |
ELI LILLY & Co
|
2,762 | $3,312,825 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,933 | $2,432,890 | |
| 4 | ABBV |
AbbVie Inc.
|
7,570 | $1,904,914 | |
| 5 | PFE |
Pfizer Inc
|
44,347 | $1,067,875 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,952 | $625,635 | |
| 7 | AMGN |
Amgen Inc
|
1,572 | $569,252 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,494 | $489,424 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,276,346 | 16,838 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $4,104,880 | 16,793 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,594,307 | 17,368 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,782,382 | 20,399 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,146,802 | 20,601 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,513,320 | 21,185 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,333,924 | 23,053 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,773,891 | 23,287 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $11,071,912 | 75,752 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $12,071,953 | 76,313 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $11,922,114 | 76,063 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $11,897,898 | 76,391 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $12,655,824 | 76,461 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,973,440 | 77,248 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,699,737 | 77,553 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,724,600 | 77,893 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,785,426 | 77,660 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,942,152 | 78,667 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,390,162 | 78,273 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,883,339 | 79,773 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,027,968 | 79,082 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $13,367,242 | 81,334 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,890,366 | 81,906 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $12,343,343 | 82,908 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $11,835,561 | 84,161 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $11,152,737 | 85,051 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||